1. Home
  2. KLTR vs AGEN Comparison

KLTR vs AGEN Comparison

Compare KLTR & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.28

Market Cap

160.6M

Sector

Technology

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.93

Market Cap

178.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
AGEN
Founded
2006
1994
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.6M
178.2M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
KLTR
AGEN
Price
$1.28
$3.93
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.00
$14.50
AVG Volume (30 Days)
403.0K
1.0M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
100.00
EPS
N/A
N/A
Revenue
$180,854,000.00
$42,877,086.00
Revenue This Year
$2.96
$107.63
Revenue Next Year
$4.96
N/A
P/E Ratio
N/A
$8.89
Revenue Growth
1.20
89.95
52 Week Low
$1.06
$2.63
52 Week High
$2.29
$7.34

Technical Indicators

Market Signals
Indicator
KLTR
AGEN
Relative Strength Index (RSI) 56.84 49.56
Support Level $1.21 $2.96
Resistance Level $1.68 $4.58
Average True Range (ATR) 0.06 0.42
MACD 0.03 -0.03
Stochastic Oscillator 77.19 37.53

Price Performance

Historical Comparison
KLTR
AGEN

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: